Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multi-center, Double Blind, Randomized, Placebo Controlled Study of Testogel® (Testosterone Gel 50mg/5g) in the Treatment of Male Hypogonadism

NCT01786473 is registered in ClinicalTrials.gov with Laboratoires Besins International as lead sponsor.

NCT NCT01786473
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01786473 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multi-center, Double Blind, Randomized, Placebo Controlled Study of Testogel® (Testosterone Gel 50mg/5g) in the Treatment of Male Hypogonadism
Lead sponsor
Laboratoires Besins International
Phase
Phase 3
Overall status
Unknown status
Start date
December 31, 2012
Completion date
Not reported
Enrollment
240 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hypogonadism